title: Controversies in testosterone replacement therapy: testosterone and cardiovascular disease.
abstract: The role of testosterone in the cardiovascular (CV) health of men is controversial. Data suggest that both the condition and treatment of clinical hypogonadism is associated with decreased CV mortality; however, two recent studies suggest that hypogonadal subjects treated with testosterone replacement therapy have a higher incidence of new CV events. There has been increased media attention concerning the risk of CV disease in men treated with testosterone. Until date, there are no long-term prospective studies to determine safety. Literature spanning over the past 30 years has suggested that not only is there a possible increased CV risk in men with low levels of testosterone, but the benefits from testosterone therapy may even lower this risk. We review here the recent studies that have garnered such intense scrutiny. This article is intended as a thorough review of testosterone levels and CV risk, providing the clinician with the facts needed to make informed clinical decisions in managing patients with clinical hypogonadism.
authors: Department of Surgery (Urology), The Alpert Medical School of Brown University, Providence, Rhode Island, USA.
authors: Kathleen
authors: K
authors: Hwang
authors: Martin
authors: M
authors: Miner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000401:mortality; D005058:Eunuchism / Q000188:drug therapy*; D005500:Follow-Up Studies; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008297:Male; D012307:Risk Factors; D015996:Survival Rate; D013739:Testosterone / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use*
chemical_list: D013739:Testosterone
references: J Sex Med. 2010 Apr;7(4 Pt 1):1557-64
references: 20102478
references: J Clin Endocrinol Metab. 2006 Apr;91(4):1305-8
references: 16434464
references: Clin Endocrinol (Oxf). 2013 Apr;78(4):629-34
references: 22901104
references: Nephrol Dial Transplant. 2011 Sep;26(9):2971-7
references: 21427069
references: Ann Pharmacother. 2014 Jul 2;48(9):1138-1144
references: 24989174
references: Am J Epidemiol. 2010 Mar 1;171(5):583-92
references: 20083549
references: Atherosclerosis. 2009 Dec;207(2):318-27
references: 19464009
references: Expert Opin Drug Saf. 2014 Oct;13(10):1327-51
references: 25139126
references: Circulation. 2007 Dec 4;116(23):2694-701
references: 18040028
references: PLoS One. 2014;9(1):e85805
references: 24489673
references: J Clin Endocrinol Metab. 2012 Jan;97(1):179-89
references: 22013106
references: J Clin Endocrinol Metab. 2010 Oct;95(10):4542-8
references: 20926540
references: Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:52-9
references: 23280867
references: Circulation. 2005 Jul 19;112(3):332-40
references: 16009799
references: J Sex Med. 2010 Oct;7(10):3495-503
references: 20646185
references: J Clin Oncol. 2007 Jun 10;25(17):2420-5
references: 17557956
references: Eur J Endocrinol. 2013 Dec;169(6):725-33
references: 23999642
references: J Clin Endocrinol Metab. 2012 Jun;97(6):2050-8
references: 22496507
references: J Am Soc Nephrol. 2009 Mar;20(3):613-20
references: 19144759
references: Eur Heart J. 2006 Jan;27(1):57-64
references: 16093267
references: Diabetes Care. 2011 Aug;34(8):1771-7
references: 21715525
references: Cardiol J. 2010;17(3):249-53
references: 20535714
references: BMC Med. 2013;11:108
references: 23597181
references: J Am Coll Cardiol. 2009 Sep 1;54(10):919-27
references: 19712802
references: Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93
references: 16117815
references: J Clin Endocrinol Metab. 2011 Oct;96(10):3007-19
references: 21816776
references: Horm Metab Res. 2007 May;39(5):366-71
references: 17533579
references: JAMA. 2013 Nov 6;310(17):1829-36
references: 24193080
references: Circulation. 2000 Oct 17;102(16):1906-11
references: 11034937
references: Heart. 2010 Nov;96(22):1821-5
references: 20959649
references: Circulation. 2004 May 4;109(17):2074-9
references: 15096452
references: J Androl. 2009 Jan-Feb;30(1):1-9
references: 18772485
references: J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59
references: 20525905
references: Clin Endocrinol (Oxf). 2012 Sep;77(3):475-83
references: 22356136
references: Int J Androl. 2011 Dec;34(6 Pt 1):528-40
references: 20969599
references: CA Cancer J Clin. 2010 May-Jun;60(3):194-201
references: 20124400
references: Mayo Clin Proc. 2007 Jan;82(1):29-39
references: 17285783
references: J Sex Med. 2012 Jan;9(1):54-67
references: 21676183
references: Arch Intern Med. 2007 Jun 25;167(12):1252-60
references: 17592098
references: J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75
references: 20525906
references: Aging Male. 2010 Jun;13(2):108-12
references: 20001470
references: Eur J Endocrinol. 2009 Sep;161(3):435-42
references: 19542243
references: Am J Nephrol. 2011;33(3):209-17
references: 21335966
references: Eur J Endocrinol. 2006 Jun;154(6):899-906
references: 16728551
references: J Clin Endocrinol Metab. 2008 Jan;93(1):68-75
references: 17911176
references: J Clin Oncol. 2006 Sep 20;24(27):4448-56
references: 16983113
references: Clin Endocrinol (Oxf). 2010 Nov;73(5):602-12
references: 20718771
references: Diabetes Care. 2005 Jul;28(7):1636-42
references: 15983313
references: Eur Heart J. 2000 Jun;21(11):890-4
references: 10806012
references: N Engl J Med. 2010 Jul 8;363(2):109-22
references: 20592293
references: Eur Heart J. 2010 Jun;31(12):1494-501
references: 20164245